Royce & Associates’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3M | Sell |
1,582,862
-15,498
| -1% | -$336K | 0.35% | 73 |
|
|
2025
Q1 | $38.8M | Sell |
1,598,360
-265,991
| -14% | -$6.45M | 0.42% | 58 |
|
|
2024
Q4 | $38.9M | Sell |
1,864,351
-156,754
| -8% | -$3.27M | 0.36% | 65 |
|
|
2024
Q3 | $40.2M | Sell |
2,021,105
-140,917
| -7% | -$2.8M | 0.37% | 74 |
|
|
2024
Q2 | $33.5M | Buy |
2,162,022
+78,009
| +4% | +$1.21M | 0.31% | 85 |
|
|
2024
Q1 | $33.2M | Buy |
2,084,013
+340,939
| +20% | +$5.43M | 0.3% | 95 |
|
|
2023
Q4 | $29.3M | Buy |
1,743,074
+131,372
| +8% | +$2.21M | 0.27% | 98 |
|
|
2023
Q3 | $18.8M | Buy |
1,611,702
+571,714
| +55% | +$6.68M | 0.19% | 149 |
|
|
2023
Q2 | $14M | Buy |
1,039,988
+424,020
| +69% | +$5.7M | 0.14% | 209 |
|
|
2023
Q1 | $10.2M | Buy |
615,968
+84,079
| +16% | +$1.39M | 0.1% | 303 |
|
|
2022
Q4 | $9.89M | Sell |
531,889
-126,658
| -19% | -$2.36M | 0.1% | 295 |
|
|
2022
Q3 | $8.45M | Sell |
658,547
-1,441,678
| -69% | -$18.5M | 0.1% | 309 |
|
|
2022
Q2 | $14.7M | Sell |
2,100,225
-161,682
| -7% | -$1.13M | 0.15% | 186 |
|
|
2022
Q1 | $18.8M | Sell |
2,261,907
-321,961
| -12% | -$2.67M | 0.16% | 174 |
|
|
2021
Q4 | $17.5M | Sell |
2,583,868
-423,126
| -14% | -$2.86M | 0.13% | 236 |
|
|
2021
Q3 | $15.9M | Sell |
3,006,994
-66,852
| -2% | -$354K | 0.12% | 275 |
|
|
2021
Q2 | $17.7M | Sell |
3,073,846
-175,804
| -5% | -$1.01M | 0.12% | 283 |
|
|
2021
Q1 | $15M | Buy |
3,249,650
+844,521
| +35% | +$3.89M | 0.1% | 328 |
|
|
2020
Q4 | $8.03M | Buy |
2,405,129
+620,239
| +35% | +$2.07M | 0.07% | 440 |
|
|
2020
Q3 | $5.3M | Buy |
1,784,890
+474,984
| +36% | +$1.41M | 0.06% | 456 |
|
|
2020
Q2 | $6.05M | Buy |
1,309,906
+665,915
| +103% | +$3.08M | 0.07% | 409 |
|
|
2020
Q1 | $2.48M | Sell |
643,991
-136,791
| -18% | -$527K | 0.03% | 543 |
|
|
2019
Q4 | $2.93M | Buy |
+780,782
| New | +$2.93M | 0.03% | 617 |
|